This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,592.50 firm fixed-price delivery order contract is for the supply of EMGALITY 120 MG/ML PENML, a specialty medication. The contract has an ultimate completion date of December 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,576.98 firm fixed-price delivery order is for the supply of EMGALITY 120 MG/ML PENML, a medical product. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,011.52 Firm Fixed Price Delivery Order contract is for the supply of EMGALITY 120 MG/ML PENML, a prescription medication. The contract has an ultimate completion date of September 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,336.96 fixed-price delivery order is for the medication EMGALITY 120 MG/ML PENML, with a completion date of November 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.62 firm fixed-price delivery order is for EMGALITY 120 MG/ML PENML, a medical product. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,950.38 Firm Fixed Price Delivery Order contract is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4566407720 EMGALITY 120 MG/ML PENML. The $2,005.44 firm fixed-price delivery order has an ultimate completion date of November 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award, valued at $2,074.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under Indefinite Delivery Contract (IDC) SPE2DB20D3101, is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract has a firm fixed-price pricing type and a completion date of November 20, 2024. This award is not designated as a set-aside...
This federal contract award, valued at $2,425.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order to supply EMGALITY 120 MG/ML PENML medication, with a completion date of February 3, 2025. The contract is a firm fixed-price arrangement, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with ID SPE2DB24D2205|SPE2DB25FDXTJ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,556.10 Firm Fixed Price Delivery Order contract is for the provision of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract has a period of performance through February 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...